Scarica l'app Stockscreener
18.80
2.94%
-0.57
Dopo l'orario di chiusura:
18.90
0.10
+0.53%
Precedente Chiudi:
$19.37
Aprire:
$19.35
Volume 24 ore:
1.89M
Relative Volume:
0.75
Capitalizzazione di mercato:
$869.77M
Reddito:
$82.71M
Utile/perdita netta:
$-102.24M
Rapporto P/E:
-5.1226
EPS:
-3.67
Flusso di cassa netto:
$-76.57M
1 W Prestazione:
-2.29%
1M Prestazione:
-5.43%
6M Prestazione:
+95.83%
1 anno Prestazione:
+34.57%
Intervallo 1D:
$18.17
$19.48
Intervallo di 1 settimana:
$18.17
$20.20
Portata 52W:
$3.42
$21.02
Urogen Pharma Ltd Stock (URGN) Company Profile
Nome
Urogen Pharma Ltd
Settore
Industria
Telefono
972 9 770 7601
Indirizzo
9 HA'TA'ASIYA ST, RA'ANANA
Confronta URGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
URGN
Urogen Pharma Ltd
|
18.80 | 903.54M | 82.71M | -102.24M | -76.57M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-06-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-04-16 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-19 | Ripresa | Ladenburg Thalmann | Buy |
| 2024-08-22 | Iniziato | Guggenheim | Buy |
| 2023-02-08 | Downgrade | Jefferies | Buy → Hold |
| 2022-04-27 | Iniziato | Berenberg | Buy |
| 2020-04-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-13 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-09 | Iniziato | National Securities | Neutral |
| 2019-05-30 | Iniziato | JP Morgan | Neutral |
| 2019-05-29 | Iniziato | Goldman | Neutral |
| 2019-01-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-08 | Ripresa | Jefferies | Buy |
| 2018-04-04 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-01-02 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-11-15 | Reiterato | Oppenheimer | Outperform |
| 2017-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Urogen Pharma Ltd Borsa (URGN) Ultime notizie
How to use Fibonacci retracement on UroGen Pharma Ltd.July 2025 Review & Fast Gaining Stock Reports - Newser
How cyclical is UroGen Pharma Ltd.’s revenue streamEarnings Growth Report & Technical Confirmation Alerts - khodrobank.com
Will UroGen Pharma Ltd. benefit from macro trendsWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser
How to escape a deep drawdown in UroGen Pharma Ltd.July 2025 Trends & Target Return Focused Stock Picks - Newser
Using data filters to optimize entry into UroGen Pharma Ltd.July 2025 Short Interest & AI Optimized Trading Strategy Guides - Newser
Real time pattern detection on UroGen Pharma Ltd. stock2025 Price Targets & AI Driven Stock Movement Reports - Newser
Will earnings trigger a reversal in UroGen Pharma Ltd.2025 Market Outlook & Verified Short-Term Trading Plans - Newser
UroGen Pharma Ltd. stock prediction for this week2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Can momentum traders help lift UroGen Pharma Ltd.Short Setup & Daily Oversold Stock Bounce Ideas - Newser
What recovery options are there for UroGen Pharma Ltd.July 2025 Summary & Reliable Volume Spike Alerts - Newser
Will breakout in UroGen Pharma Ltd. lead to full recoveryMarket Risk Report & Real-Time Buy Signal Alerts - Newser
Visual trend scoring systems applied to UroGen Pharma Ltd.Portfolio Value Report & Safe Entry Momentum Tips - Newser
What is UroGen Pharma Ltd. s 5 year growth outlookMarket Risk Report & Technical Confirmation Alerts - khodrobank.com
Will UroGen Pharma Ltd. benefit from rate cutsJuly 2025 Chart Watch & Fast Gaining Stock Reports - khodrobank.com
Heatmap analysis for UroGen Pharma Ltd. and competitorsJuly 2025 Fed Impact & Technical Buy Zone Confirmations - Newser
How hedge fund analytics apply to UroGen Pharma Ltd. stock2025 Support & Resistance & Long-Term Safe Return Strategies - Newser
Is UroGen Pharma Ltd. stock overvalued or fairly pricedQuarterly Portfolio Summary & Low Risk Entry Point Guides - khodrobank.com
Institutional scanner results for UroGen Pharma Ltd.Earnings Growth Summary & Technical Pattern Based Buy Signals - Newser
Does UroGen Pharma Ltd. have declining or rising EPSQuarterly Investment Review & Verified Technical Trade Signals - khodrobank.com
Comparing UroGen Pharma Ltd. in custom built stock radarsQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
What is UroGen Pharma Ltd. s P E ratio telling usJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - khodrobank.com
Historical volatility pattern of UroGen Pharma Ltd. visualizedTrade Volume Summary & Weekly Top Gainers Alerts - Newser
Analyzing drawdowns of UroGen Pharma Ltd. with statistical toolsJuly 2025 Momentum & Daily Profit Focused Screening - Newser
Can UroGen Pharma Ltd. keep up with sector leadersJuly 2025 Retail & Safe Investment Capital Preservation Plans - khodrobank.com
Is Now a Good Time to Reenter UroGen Pharma Ltd. getLinesFromResByArray error: size == 0 - thegnnews.com
Why UroGen Pharma Ltd. stock attracts strong analyst attentionBull Run & Capital Efficient Trading Techniques - Newser
Non Muscle Invasive Bladder Cancer Pipeline Insight Report 2025 | Phase III Clinical TrialsPromising New Drug DevelopmentsResearchAndMarkets.com - FinancialContent
Technical Models Suggest UroGen Pharma Ltd. May Rebound Soon getLinesFromResByArray error: size == 0 - thegnnews.com
How to integrate UroGen Pharma Ltd. into portfolio analysis toolsWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser
UroGen Pharma Ltd. stock trend outlook and recovery pathJuly 2025 Drop Watch & Real-Time Volume Analysis - Newser
UroGen Pharma Ltd. Shows Early Signs of Technical Strength getLinesFromResByArray error: size == 0 - 더경남뉴스
Is now a turning point for UroGen Pharma Ltd.July 2025 Intraday Action & Verified Swing Trading Watchlists - Newser
Top chart patterns to watch in UroGen Pharma Ltd.Earnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is UroGen Pharma Ltd. stock poised for growthPortfolio Gains Report & Verified High Yield Trade Plans - Newser
UroGen Pharma Ltd. Stock Recovery Path — Analyst Breakdown getLinesFromResByArray error: size == 0 - kangso.co.kr
Urogen Pharma Ltd Azioni (URGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Urogen Pharma Ltd Azioni (URGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Smith Jason Drew | General Counsel |
Jul 28 '25 |
Sale |
19.14 |
7,522 |
143,971 |
41,492 |
| Schoenberg Mark | Chief Medical Officer |
Jul 28 '25 |
Sale |
19.14 |
5,149 |
98,552 |
158,229 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):